---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "ZI2xM/++QavT3upR9mnzlqmdS5ZxPovTwhT+G/PIhIN9nfyum3uBkkt4b3KxK7DTjrSH+dKR61LnH7cQTox9Wl3/K5taSeRqiO3byOduVMtc/2GLZqiXJBojT4nFT3WrI2KzKXP7K3KXe+TdxxMRLKHJmdRD5QDRpTgZffZfsNbeA7jc8cwhCHA2+zKsAp5XOBvl/x9jLULHcl1kLUnXgQfG+Y1/cbEshvp83aqMQltO+6pjP0VxoqVh34SQmYSKckIQayfm8FtHXzBJXpxDQioHRzxTrXTQVBZz0ss1ejdVJDNbqjEDmDC1R2Xa83bxHzeJCbWUcQSi8xVpixSB3LWSvF+EB6spJbg0S2bdpVc=;YC6ssP6qtPGvUINjX7iV0w=="
---

